The largest database of trusted experimental protocols

15 protocols using gsk2578215a

1

Differentiation of Stem Cells into Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
EZ spheres were differentiated into dopaminergic neurons using fibroblast growth factor-8, purmorphamine, and growth factors as described previously (Ebert et al., 2013 (link)). Telencephalic excitatory projection neurons were derived from EZ spheres as described previously (Ebert et al., 2013 (link)). Sensory neurons were derived from monolayer iPSCs as described previously (Chambers et al., 2012 (link)). For LRRK2 kinase inhibition experiments, 1 μM GSK2578215A (Tocris) was added at every feeding starting at 1 week prior to endpoint analysis. DMSO (1 μM) was used as the vehicle control. All analyses were performed at 5 weeks of total differentiation for dopaminergic neurons and 4 weeks of total differentiation for glutamatergic and sensory neurons.
+ Open protocol
+ Expand
2

Obtaining and Characterizing Small Molecule Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
GSK2578215A (Reith et al, 2012) was obtained from Tocris or GlaxoSmithKline; MLI‐2 (Fell et al, 2015) was obtained from Merck; Bafilomycin A1 (#B1793) was obtained from Sigma, and HG‐10‐102‐01 (Choi et al, 2012), LRRK2‐IN1 (Deng et al, 2011) and Vps34‐IN1 (Bago et al, 2014) were custom synthesised by Natalia Shapiro (University of Dundee, UK).
+ Open protocol
+ Expand
3

Differentiation and Manipulation of Human and Rat Neuronal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human SH-SY5Y cells were cultured in DMEM containing 10 % fetal bovine serum at 37 °C with 5 % CO2 and differentiated in medium containing all-trans retinoic acid (10 μM) for 6–7 days to obtain dopaminergic neuron-like properties.
Rat primary cortical neuron cultures were carried out as described previously [31 (link)]. The LRRK2 specific kinase inhibitors LRRK2 IN-1 (438193, Merck Millipore, Darmstadt, Germany) and GSK2578215A (4629, Tocris Biosciences, Bristol, United Kingdom) was added as indicated. Transfection of plasmid was carried out with Lipofectamine LTX (Invitrogen) as recommended by the manufacturer.
+ Open protocol
+ Expand
4

Mitophagy and Neurodegeneration Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DMEM-F12 (Dulbecco's modified Eagle's medium), penicillin–streptomycin, gentamicin and fetal bovine serum (FBS) were purchased from Gibco-Invitrogen (Carlsbad, CA, USA). GSK 2578215A and LRRK2-IN-1 were purchased from Tocris Bioscience (Minneapolis, MN, USA). Stealth RNAi duplexes were purchased from Life Technologies (Carlsbad, CA, USA). BCA protein assay was from Pierce (Rockford, IL, USA). The pDsRed2-mito vector was provided by Clontech (BD Biosciences, San Jose, CA, USA), GFP-LC3 was provided by Dr. JM Fuentes (Universidad de Extremadura, Badajoz, Spain), Drp1-GFP was provided by T Wilson and Dr. S Strack (Department of Pharmacology, University of Iowa Carver College of Medicine, Iowa City, IA, USA) and mRFP-GFP-LC3 was provided by Dr. E Kneck (Laboratory of Cellular Biology, Centro de Investigación Príncipe Felipe, Valencia, Spain). Anti-4 hydroxynonenal and LRRK2 antibodies were purchased from Abcam (Cambridge, UK); anti-p62 from BD (San Jose, CA, USA) and Alexa Fluor 488 were from Molecular Probes (Carlsbad, CA, USA), Invitrogen (Carlsbad, CA, USA); and anti-acetylated tubulin was from Sigma-Aldrich (St. Louis, MO, USA). The TUNEL method (MEBSTAIN Apoptosis Kit) was purchased from MBL (Carlsbad, CA, USA). Mdivi-1 was purchased from Sigma-Aldrich.
+ Open protocol
+ Expand
5

Dissolving IN-1 and GSK2578215A

Check if the same lab product or an alternative is used in the 5 most similar protocols
IN‐1 and GSK2578215A were purchased from Tocris Bioscience (Bristol, UK). Both compounds were dissolved in DMSO to 10 mmol L−1, then diluted with Krebs at the tested concentrations.
+ Open protocol
+ Expand
6

LRRK2 and RAB Transfection in HEK293T and SH-SY5Y Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were cultured as described (Madero-Perez et al., 2018 (link)) and transfected at 80% confluence with 2 μg of LRRK2 constructs and 200 ng of RAB constructs where indicated, and 6 μl of LipoD293 (SignaGen Laboratories) per well of a 6-well plate for 5 h in full medium, resulting in a roughly 30% transfection/co-transfection efficiency, respectively. Cells were split 1:5 the following day, and processed for immunocytochemistry or Western blotting 48 h after transfection.
SH-SY5Y cells stably expressing GFP, flag-tagged wildtype LRRK2, or flag-tagged G2019S-mutant LRRK2 were cultured as described (Madero-Perez et al., 2018 (link)) and subcultured at a ratio of 1:6 twice a week. Transfection of cells was carried out at 80% confluence with 0.4 μg of DNA and 1.5 μl of Lipofectamine 2000 (Invitrogen) per well of a 24-well plate in 200 μl OptiMEM. Five hours later, cells were changed into full medium, passaged the following day at a 1:5 ratio onto coverslips, and fixed and stained 72 h after transfection.
Where indicated, cells were treated with brefeldin A (7.5 μg/ml, Sigma-Aldrich) or with nocodazole (200 nM, Sigma-Aldrich) for 3 h, or with 100 nM MLi2 (MRC PPU, Dundee, United Kingdom), 500 nM LRRK2-IN1 (obtained through the MJFF) or 500 nM GSK2578215A (Tocris) for 1 h before fixation.
+ Open protocol
+ Expand
7

Reagents for Immune Cell Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for cell stimulation: purified anti-mouse CD38 (Clone 90; BioLegend, 102702), purified rat IgG2a, κ isotype control (Clone RTK2758; BioLegend, 400565). In certain experiments, the following reagents/inhibitors were used at the indicated concentration in cell culture: LPS (E. Coli Serotype R515; Enzo Life Sciences, ALX-581-007-L001), NAADP-AM (3 μM; AAT Bioquest, 21000), GSK2578215A (LRRK2 inhibitor, 1 µM; Tocris Bioscience, 4629), GPN (200 µM; Santa Cruz Biotechnology, sc-252858), EDTA (2 mM; Sigma-Aldrich, E6758), thapsigargin (500 nM; Tocris Bioscience, 1138), 8-Br-cADPR (100 µM; BIOLOG Life Science Institute, B065), 8-Br-ADPR (100 µM; BIOLOG Life Science Institute, B051), Ned-19 (100 µM; Cayman Chemical, 17527), cyclosporine (10 µM; R&D Systems, 1101/100), FK506 (5 nM; Eton Bioscience Inc, 1100060052), CHIR 99021 (GSK3B inhibitor, 5 µM; Tocris Bioscience, 4423), BAPTA-AM (10 µM; R&D Systems, 2787), EGTA-AM (10 µM; AnaSpec Inc, AS-84100), GSK2606414 (EIF2AK3/PERK inhibitor, 10 µM; Tocris Bioscience, 5107), and dorsomorphin (5 µM; Tocris Bioscience, 3093).
+ Open protocol
+ Expand
8

Inhibitors of Microtubule Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Trichostatin A, tubacin and nocodazole were from Sigma Aldrich, PTL from Eurodiagnostico, LRRK2-IN1, TAE684 and CZC25146 from the Michael J. Fox Foundation, GSK2578215A from Tocris, compound 68 (ID 9108605) and compound 70 (ID 9119202) from Chembridge Corporation (San Diego, USA), and GNE-0877 and GNE-7915 from MedchemExpress (USA), and MLi2 from MRC PPU, Dundee, UK. Natural streptolysin-O was from Abcam (ab63978), and non-hydrolyzable GTP test kit from Jena Bioscience (NK-102).
+ Open protocol
+ Expand
9

LRRK2 inhibitor-mediated autophagy regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chemical compounds were purchased as follows: LRRK2in1 [24 (link)] from the Division of Signal Transduction Therapy, School of Life Sciences, University of Dundee, U.K.; GSK2578215A and MLi-2 from Tocris [25 (link)]; bafilomycin-A1 (B1793-2UG) and cycloheximide (01810-1G) from Sigma-Aldrich; torin-1 (CAY10997) from Cayman Chemicals. Antibodies used were as follows: LC3 (NB100-2220, Novus Biologicals); total P70S6K (sc-8418, Santa Cruz); phospho Thr389 P70S6K (sc-11759, Santa Cruz); p62 (610833, BD Transduction Labs); total ULK1 antibody (8054 and 4773, Cell Signalling); phospho Ser757 ULK1 antibody (6888 and D7O6UCell Signalling); phospho Ser555 ULK1 antibody (5869, Cell Signalling); total LRRK2 antibody (MJFF2, Abcam); phosphor Ser935 LRRK2 antibody (UDD2, Abcam) and β-actin (A1978, Sigma-Aldrich). AMPK activator (A769662) was kindly provided by Dr MPMS.
+ Open protocol
+ Expand
10

Stimulating Cell Responses with Diverse Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Where indicated, cells were treated with recombinant human IFN-γ (R&D Systems), LPS (LPS from E. coli O111:B4), poly(I:C) (both Invivogen), ionomycin, MG132, colchicine, PMA (all from Sigma-Aldrich), LRRK2-IN-1 and GSK2578215A (both Tocris), Mli-2 (Abcam), MCV1 (HPVIVIT, Calbiochem), recombinant human NRG1 (BioLegend), and PTX (STEMCELL Technologies).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!